Skip to content
MARKETS / NYSE / MTD
NYSE · LABORATORY ANALYTICAL INSTRUMENTS · LARGE CAP

Mettler Toledo International Inc/ MTD

15 fiscal years on record · USD · FY2025 reported · SEC filings only
$4.0B
▲ 4.0% YoY
$869.2M
▲ 0.7% YoY
$848.6M
▼ 1.8% YoY
In brief

What this company does

Mettler-Toledo manufactures a wide variety of precision instruments and provides value-added services to its customers. Net sales in 2025 were derived 42% from North and South America, 29% from Europe, and 29% from Asia and other countries. Its total global workforce was approximately 18,100, consisting of 16,600 employees and 1,500 temporary personnel, as of December 31, 2025. It is a worldwide manufacturer, with facilities principally located in China, Switzerland, the United States, Germany, the United Kingdom, and Mexico. It has five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The laboratory instruments and related service business accounted for approximately 56% of its net sales in 2025 and 2024, compared to 55% in 2023. The industrial instruments and related service business accounted for approximately 39% of its net sales in 2025, 2024 and 2023. Mettler-Toledo International Inc. was incorporated as a Delaware corporation in 1991 and became a publicly traded company with its initial public offering in 1997.

Written from the business description in Mettler-Toledo International Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 6 February 2026. Every sentence was checked against that document before publication.

Growth
USD 4.0B
Revenue, FY2025 · full 15-year series below
Revenue $B Net income $B
FY2025 · Revenue 4.0 · Net income 0.9
2B4B20082010201220172019202120232025
Compound annual growth
+0.9%
+5.5%
+4.9%
−0.1%
+7.6%
+9.2%
+3.1%
+11.0%
+12.9%
−10.4%
+0.5%
+8.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +5.5% a year over five years — but profit grew faster: net income at +7.6%, earnings per share at +11.0%.

The share count fell from 0.02B to 0.02B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
22 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 26.1% · Net 21.6%
10%20%20082010201220172019202120232025
ROE
FY2022 · ROE 889.3%
500%20082010201220172019202120232025

Cash & shareholders
USD 767.7M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 848.6
400M800M20082010201220172019202120232025
Net buybacks $B Dividends $B
FY2025 · Dividends — · Net buybacks 0.8
0.4B0.8B20082010201220172019202120232025

USD 767.7M in buybacks — 88% of the year's profit went back to shareholders.

Total assetsUSD 3.7B
EquityUSD -23.6M
CashUSD 66.9M
Gross debtUSD 2.2B
Net debtUSD 2.1B
Current ratio1.14×

Equity was negative — liabilities exceeded assets. No ratio is shown.

The 15-year record
15 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 202520242023202220212020201920182017201320122011201020092008
Revenue $B4.03.93.83.93.73.13.02.92.72.42.32.32.01.72.0
Operating income $B1.01.01.01.10.90.70.7········
EBITDA $B1.11.11.01.11.00.80.7········
Income tax $B0.20.20.20.20.20.10.10.10.20.10.10.10.10.10.1
Net income $B0.90.90.80.90.80.60.60.50.40.30.30.30.20.20.2
Free cash flow $B0.80.90.90.70.80.60.50.40.40.30.20.20.20.20.2
EPS, diluted $42.0540.4835.9038.4132.7824.9122.4719.8814.249.969.148.216.805.035.79
Dividend / sh $···············
Payout %···············
ROE %···889.3338.7171.4111.090.168.734.736.234.731.328.440.3
Shares out B0.020.020.020.020.020.020.020.02·0.030.030.030.030.03·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures · 6 divergences in 62 reconciliationsAUDITED

Reconciled in 9 of 19 fiscal years. 6 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 33 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures6 divergent
ActivityLaboratory Analytical Instruments
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image